Skip to main content

Linda B. Azrin

Special Counsel

[email protected]

+1.617.348.1737

Share:

Linda helps clients build and maintain patent portfolios to protect their most valuable assets. She is a seasoned patent prosecutor and strategist with experience in the medical device, life sciences, and consumer products industries.

Her practice emphasizes strategic portfolio assessment and counseling, issuing patentability, invalidity, non-infringement, and freedom-to-operate opinions, and transactional due diligence. Linda provides insights into the competitive marketplace as clients development new and enhance existing products. She also monitors status of competitors’ patent applications, patent office proceedings, and patent litigation in order to help clients maintain competitive advantage.

Linda most frequently works with portfolios containing mechanical, material, and chemical innovations. She has helped clients protect medical devices, materials, and techniques relating to bone repair, surgical staplers, optical applications, diabetes monitoring systems, dental applications, catheters, and drug delivery systems such as drug-coated stents and drug patches; pharmaceutical compositions; nanotechnology applications; ink compositions; industrial coatings; pet food; and consumer products such as cosmetic sampler packages; writing instruments; razors; and energy storage devices.

During law school, Linda was a research assistant for The Honorable Judge Kimberly Moore in the United States Court of Appeals for the Federal Circuit, who was a professor at the time. Linda also gained significant practical experience while working as a chemist at DuPont NEN Medical Research Products between college and law school. While attending Brandeis University, Linda worked in Nobel laureate Jeffrey C. Hall’s lab for research on the circadian rhythm of Drosophila.

Education

  • Chicago-Kent College of Law (JD)
  • Brandeis University (BA, Chemistry, cum laude)

Involvement

  • Member, Boston Patent Law Association
  • Member, Boston Bar Association

Viewpoints

Most people are familiar with blockchain technology because of its use in cryptocurrency, but its use is going to be far more widespread than just as a ledger for digital currency. 
Further to our previous blog post, the U.S. Patent and Trademark Office reported that the 10 millionth patent issued today with the new patent cover design.
The U.S. Patent and Trademark Office (USPTO) is implementing eCommerce Modernization (eMod), as discussed at a Patent Quality Chat webinar on May 9, 2017.
The U.S. Patent and Trademark Office (USPTO) announced this week that the Global Dossier program has expanded to include access to more patent applications worldwide.
The U.S. Patent and Trademark Office (USPTO) explains several patent prosecution trends, goals, and programs to justify proposed spending of its collected fees in its recently-issued Fiscal Year 2017 Congressional Justification report.
The Japanese Patent Act was revised on May 14, 2014 to provide for post-grant oppositions within one year of the rule change, i.e., by May 14, 2015 (the exact effective date has not yet been set). Under the new opposition system, any party, including non-interested parties and straw men, will be able to file an opposition within 6 months of patent issuance and thus potentially cause invalidation soon after patent grant.
On September 16, 2014, United States Patent and Trademark Office Chief of Staff Andrew Byrnes presented to the Boston Patent Law Association an update on new quality initiatives and the implementation of White House patent policies.